Literature DB >> 24431297

ATP1A3 mutations: what is the phenotype?

Allison Brashear1, Laurie J Ozelius, Kathleen J Sweadner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24431297     DOI： 10.1212/WNL.0000000000000113

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  4 in total

1.  Beyond Dystonia-Parkinsonism: Chorea and Ataxia with ATP1A3 Mutations.

Authors:  Claudio M de Gusmao; Marisela Dy; Nutan Sharma
Journal:  Mov Disord Clin Pract       Date:  2016-01-29

2.  Modular and coordinated expression of immune system regulatory and signaling components in the developing and adult nervous system.

Authors:  Jimena Monzón-Sandoval; Atahualpa Castillo-Morales; Sean Crampton; Laura McKelvey; Aoife Nolan; Gerard O'Keeffe; Humberto Gutierrez
Journal:  Front Cell Neurosci       Date:  2015-08-28       Impact factor: 5.505

Review 3.  Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders.

Authors:  Sarah van Veen; Danny M Sørensen; Tine Holemans; Henrik W Holen; Michael G Palmgren; Peter Vangheluwe
Journal:  Front Mol Neurosci       Date:  2014-05-27       Impact factor: 5.639

4.  De novo p.Arg756Cys mutation of ATP1A3 causes an atypical form of alternating hemiplegia of childhood with prolonged paralysis and choreoathetosis.

Authors:  Hikaru Kanemasa; Ryoko Fukai; Yasunari Sakai; Michiko Torio; Noriko Miyake; Sooyoung Lee; Hiroaki Ono; Satoshi Akamine; Kei Nishiyama; Masafumi Sanefuji; Yoshito Ishizaki; Hiroyuki Torisu; Hirotomo Saitsu; Naomichi Matsumoto; Toshiro Hara
Journal:  BMC Neurol       Date:  2016-09-15       Impact factor: 2.474
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.